Rosa Rodriguez-Monguio

Summary

Affiliation: University of Massachusetts
Country: USA

Publications

  1. pmc Healthcare cost of type 1 diabetes mellitus in new-onset children in a hospital compared to an outpatient setting
    Christopher F Jasinski
    School of Public Health and Health Sciences, University of Massachusetts, Amherst, 715 N Pleasant Street, Amherst, MA 01003, USA
    BMC Pediatr 13:55. 2013
  2. pmc Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies
    Diane Nguyen
    International Center of Pharmaceutical Economics and Policy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115, USA
    BMC Health Serv Res 13:27. 2013
  3. pmc Incentives for orphan drug research and development in the United States
    Enrique Seoane-Vazquez
    Division of Pharmacy Practice and Administration, College of Pharmacy, Ohio State University, Columbus, Ohio, USA
    Orphanet J Rare Dis 3:33. 2008
  4. pmc Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy
    Satish Valluri
    College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA
    BMC Health Serv Res 7:122. 2007
  5. doi request reprint Patent life of antiretroviral drugs approved in the US from 1987 to 2007
    Rosa Rodriguez-Monguio
    School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA, USA
    AIDS Care 21:760-8. 2009

Collaborators

  • Enrique Seoane-Vazquez
  • Diane Nguyen
  • Christopher F Jasinski
  • Satish Valluri
  • Holley Allen
  • Michael Montagne
  • Ksenia Tonyushkina
  • Sheryl L Szeinbach

Detail Information

Publications5

  1. pmc Healthcare cost of type 1 diabetes mellitus in new-onset children in a hospital compared to an outpatient setting
    Christopher F Jasinski
    School of Public Health and Health Sciences, University of Massachusetts, Amherst, 715 N Pleasant Street, Amherst, MA 01003, USA
    BMC Pediatr 13:55. 2013
    ..e. hemoglobin A1C), healthcare utilization and costs among new-onset type 1 diabetic children who received initial diabetes education and care in a hospital compared to those children in an outpatient pediatric endocrinology clinic...
  2. pmc Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies
    Diane Nguyen
    International Center of Pharmaceutical Economics and Policy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115, USA
    BMC Health Serv Res 13:27. 2013
    ....
  3. pmc Incentives for orphan drug research and development in the United States
    Enrique Seoane-Vazquez
    Division of Pharmacy Practice and Administration, College of Pharmacy, Ohio State University, Columbus, Ohio, USA
    Orphanet J Rare Dis 3:33. 2008
    ..This study analyzed the characteristics of OD designations, approvals, sponsors, and evaluated the effective patent and market exclusivity life of orphan new molecular entities (NMEs) approved in the US between 1983 and 2007...
  4. pmc Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy
    Satish Valluri
    College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA
    BMC Health Serv Res 7:122. 2007
    ..This study compares drug utilization and drug product cost in community vs. mail order pharmacy dispensing services in a Medicaid population...
  5. doi request reprint Patent life of antiretroviral drugs approved in the US from 1987 to 2007
    Rosa Rodriguez-Monguio
    School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA, USA
    AIDS Care 21:760-8. 2009
    ..ARVs had an average of 2-3 more years of effective patent life than other therapeutic classes and, therefore, a longer period without generic competition...